Scenario card · Executive edition · BioGenix · source: the Winnti card
An attacker has been inside a life-sciences company for weeks, and the executives are told at one o'clock. This card gives you the story, the cast, the injects and the three Executive Decisions for a session of about an hour. It follows the rulings in the guide. Where a detail is open, it says so, and you rule.
core/rulings.md. Assumed
From source card The hook: it is Thursday, 13:00. The CISO's first line to the teams in the source card is "we do not yet know if we are compromised". Here your technical team has found out that you are. What you cannot afford is to be the last to know.
From source card BioGenix is a life-sciences company built on a precision-fermentation platform. Its crown jewel is GenixLibrary, three years of proprietary genomic sequence research. It recently merged with another firm and is still integrating infrastructure. Active fermentation projects depend on the library.
Ruled Table rule for this card: the table never sees technical artifacts such as logs, scans, certificates or tool names. Everything it sees is business language and management exhibits. Plain words such as "system" or "research cloud" are fine; never state jargon or say "this is a supply chain compromise". New for this card
Ruled The Escalation Card has a severity cell and a page rule. Put it on the table with the first brief, so the table can see why it is called now. The routing rule is an illustration of how a firm might route, not a claim about every firm. New for this card
Assumed Time budget: the first brief and escalation card 2 minutes, each short brief 20 seconds, the challenge 30 seconds, five minutes in total. If a run goes long, shorten the short briefs. A brief carries what a decision needs and never explains why it happened: causes stay Unknown until a player asks. Before a vote the CISO states one sentence: "we are deciding X because we know Y and do not know Z". If it is missing, wait for it; do not refuse the vote. Assumed Opening round, 60 seconds, after the read-aloud and the brief. In seat order (CEO, CFO, CIO, CISO), one sentence each, written on the seat card, never scored, no debate. Say: "Speaking as your seat, with your own judgment: state the one risk this warning creates for BioGenix that your seat owns. Say it as 'if this happens, then that', in your own words, not as a category." If an answer is a category word, is generic or is about last time, say once: "Say it as if-then, for BioGenix, today." The debrief lays each line beside the seat's votes: did the decisions reduce that risk, accept it or trade it for another?
Ruled The other NPCs are General Counsel, Head of Communications, COO and Chief Risk Officer. They give facts, advice, questions and pressure, and never vote, decide or roll. A fifth to eighth player converts an NPC into a seat with one vote, in this order: General Counsel, Head of Communications, COO, Chief Risk Officer. A converted seat has no specialty strengths. A decision passes by strict majority: 3 of 4, 3 of 5, 4 of 6, 4 of 7, 5 of 8. A tie fails. New for this card The CTO and the VP R&D come from the source card; you voice them as the technical team and research leadership. They are never seats. This card uses General Counsel and Head of Communications most.
Assumed This is a plan for a workshop slot of about an hour, 56 minutes on paper plus about 4 minutes of float. It is arithmetic, never played. The game itself has no hard stop: your IM decides whether and when to call time. Inject times such as 13:00 are story time, not table minutes. The three-act shape: Act 1 sets up why now and who has skin in the game; Act 2 escalates, and things worsen the longer the table waits; Act 3 is the climax and the verdict, then the debrief. If a run goes long, cut in this order: the consultant offer, Exhibit B (show it in the debrief), the false lead, then merge Decisions 1 and 2. A fourth Executive Decision is never added.
Each inject arrives as a person who wants something, carries a price and a deadline, and ends in a question to a seat. Inject 2 of the source card is merged into inject 1, so the deck is numbered 1, 3, 4, 5, 6. One full brief at the start, then a short brief at each inject. New for this card
HearsAn old system that was supposed to be switched off has been sending your research data out. The technical team can prove an attacker is using it. Cutting it off will also cut a research collaboration link, and the CTO needs a name. From source card
Ask-gated"How did they get in?" or "What did we agree with the supplier?" CTO: "Through software from one of our suppliers. Ask General Counsel what we agreed with them." (Exhibit A.) "Why is it still on?", "Who owns it?", or the VP R&D's "IT says it's in maintenance" followed by "check it": CTO: "That record says switching it off was postponed to keep research running. It says: the owner has since left, no handover." (Exhibit B.) If nobody has asked by the end of the first question window, ask one seat: "CFO, what do you want to know before you decide?"
The first callA leadership call, not an Executive Decision: the CEO names the executive incident lead, the owner of the old system and the contact for the CSIRT. Anyone may object, which forces a 3-of-4 vote. No roll, a one-minute timer, and it does not count against the three decisions. Ruled If nobody is named, the attacker reaches more research systems: Security one step worse before Decision 1. Assumed
False leadThe VP R&D says "IT says that system is in maintenance." The record is really a decommissioning blocker. The table can ask the CTO to check. From source card
HearsThe attacker also holds an open door into your research environment, left over from the old arrangement. The CTO can shut every way in within the hour, but the research collaboration link goes dark with it. From source card
Two pricesVP R&D: "Every day that link is dark, we lose ground we cannot win back, and our stakeholders will ask why." CTO: "Every hour it stays open, the attacker can keep reading." The table is asked how long research may be exposed, and how long it may be dark.
False leadThe research lead's comfort: "It's probably just the quarterly refresh." It is a bias trap: that project is documented and separate, and the data is going somewhere new.
ThenCall Executive Decision 1.
HearsCore research data has been leaving for weeks, in small quantities that looked routine and that nothing flagged. From source card
NPCCTO: "My team cannot put its hand on its heart that the research environment is clean for at least a day on our own." General Counsel: "Whether this triggers a duty to notify anyone depends on our sector and jurisdiction. I will have an assessment before you speak to stakeholders. Do not call this 'not notifiable' until I do."
Table questionWhose time, and what exposure: certification is much faster if the integration team is pulled off integration, but the integration work slips. If Decision 1 cut the system off, the leaking has stopped and the CTO says so, but still cannot promise there is no other way out. If not, the CTO says more is leaving now.
ThenCall Executive Decision 2. Inside its timer: the restart vote and the consultant offer.
HearsThe CSIRT confirms at least three other life-sciences victims in six months and asks BioGenix for its findings so it can warn others. From source card
TensionSharing helps the sector, but the findings expose BioGenix's own weaknesses, recovery work competes for the same people.
Red flagNo single owner for CSIRT coordination. From source card
ThenCall Executive Decision 3. At the end of play the CEO writes one name in the Decision Record: who is accountable for fixing what this showed, and by when. It is not a condition of containment.
HearsOnly what the table actually achieved, narrated by you in two sentences: the ways in that were shut, whether the leaking has stopped, and what is still open.
ContainmentYou declare it. Ruled You declare it only after Decision 3 has resolved. This card's test: two marks are set, Ways in shut and Leak stopped; they are necessary, not sufficient. Assumed If they are not when you call time, the verdict says "not yet reached" and the cost sentence is read.
Assumed All durations are untested. The timer is a pacing tool, not a score. In the debrief ask what the pressure did to each decision, and what the table would have decided with ten more minutes.
Ruled The menus are fixed by this card. New for this card A "+1" is one step worse on the risk board; the costs, roll targets and complications are printed on the option cards, so you never judge difficulty on the day. For each decision: read its brief, start the timer, let the table set the triangle and vote, roll only if the outcome is in doubt, then narrate and move the board.
Held by the CIO. The technical team keeps a copy of the evidence in every option; the table decides how long research stays dark or exposed. New for this card
Dark now. Research is paused today on everything that depends on the link, and the technical team shuts every way in.
Cost on the boardFinancial +1 now; Reputational +1 when Decision 3 resolves, unless Decision 3 is Open
Roll targetnone if an owner was named in the first call, else 10+
ComplicationFinancial +1 (the shutdown breaks more of the link)
A bounded exposure window. The link stays open under watch for one hour of story time, ending before inject 5, while the technical team builds a temporary link.
Cost on the boardSecurity +1
Roll target10+
ComplicationSecurity +1 (the attacker reads more research data)
Wait for the temporary link, no limit. On the menu because real teams choose it to protect research. Wait option
Cost on the boardSecurity +2
Roll target15+, it goes against the CTO's stated fact
ComplicationSecurity +1 and Financial +1 (the attacker finishes copying the most valuable data)
Triangle tensionTime (shut them out) against Money (protect research continuity).
MeanwhileAt half time CTO: "The attacker still has a door into the research environment while you talk." VP R&D: "Every day that link is dark, we lose ground we cannot win back."
Held by the CFO. Inside this timer sit the restart vote and the consultant offer. New for this card
Pull the integration team off integration and onto the response. Certification takes hours, not a day.
Cost on the boardFinancial +2, and the integration work slips a week
Roll targetnone, the CIO has clear ownership
Complicationnone
Authorise emergency budget and overtime and keep the integration work on schedule. Certification takes about a day and a half.
Cost on the boardFinancial +1
Roll target10+
ComplicationReputational +1 (overtime burns out the team and certification slips)
Run it with the internal team only. Certification takes more than a day; the research environment stays offline longer. Wait option
Cost on the boardReputational +1
Roll target10+
ComplicationReputational +1 (a stakeholder calls the CEO before certification)
Restart before certificationA leadership call, voted 3 of 4, not counted against the three decisions. "Do you reopen research before it is certified?" Yes accepts the technical team's stated risk. Roll target 15+; if it lands, Financial one step better (not below Steady); complication Security +1. Assumed
MeanwhileAt half time the IM reads the CFO's line: "Every day the integration team stays off integration costs us money and a week of slippage." CTO: "I cannot certify the research environment is clean for at least a day on our own."
Held by the CISO, who speaks for the CSIRT; General Counsel gates what may be shared. One stance, one vote, one roll. New for this card
Open. Share the findings with the CSIRT now with stated confidence, tell stakeholders now with a calibrated statement, and send the supplier a formal demand for an explanation.
Cost on the boardFinancial +1
Roll target10+
ComplicationReputational +1 (a later scope revision hurts credibility)
Measured. Share a validated subset with the CSIRT, tell stakeholders once the scope is firmer, and ask the supplier for a call.
Cost on the boardReputational +1
Roll targetnone if the CSIRT contact was named in the first call and General Counsel confirmed what may be shared, else 10+
ComplicationSecurity +1 (the subset omits something the CSIRT needed)
Hold. Say nothing until the investigation completes. Wait option
Cost on the boardReputational +2
Roll target15+, General Counsel already said the CSIRT will assume BioGenix is withholding
ComplicationReputational +1 (the CSIRT escalates its request)
MeanwhileAt half time General Counsel: "If we say nothing, the CSIRT will assume we are withholding. If we say too much, I cannot take it back." A table that wants a hybrid records it as a dissent on the card; it is not a menu item.
The layers are for the debrief. Never state them. The table meets them only as management documents and people's words, handed over when a player asks. If a table never asks, do not give: show the exhibits in the debrief and ask what they say. New for this card
The root layer is not reachable within the timers. The project owner's note and the CSIRT's request are not secret exhibits. The debrief steers to the organisation's decision record, never to blaming a player.
Ruled After the CTO's estimate at inject 4 the table may buy outside help, once, inside Decision 2's timer, by majority vote. It is not one of the three Executive Decisions. Before the vote, read the cost aloud, flat: "a new, uncontracted emergency engagement; it cannot contribute inside this window."
The mechanics themselves are ruled in the guide. These are the working defaults this card runs on, so you can run it. Each can change without touching the story, and the IM can rule differently. IM ruling space
Ruled Close with the two-part verdict, not a score: whether containment was reached, or not yet reached if you called time first, and one sentence on the cost read off the risk board. If a risk is at Critical, say so. Then debrief as a guide, never a judge. The plan allows about 13 minutes. Assumed
Derived from the vanilla Winnti scenario card (BioGenix), script v0.35 and card texts v0.2. The mechanics come from core/rulings.md.